Phospholipid profiles of invasive human breast cancer cells are altered towards a less invasive phospholipid profile by the anti-inflammatory agent indomethacin

Advances in Enzyme Regulation

Volumn 40, Issue 1, 2000, Pages 271-284

  Natarajan, K ^a   Mori, N ^a   Artemov, D ^a   Aboagye, E O ^a   Chacko, V P ^a   Bhujwalla, Z M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHOLIPID; PROSTAGLANDIN E2;

BREAST CANCER; BREAST TUMOR; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CELL LINE; CONFERENCE PAPER; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; LIPID ANALYSIS; METABOLISM; METASTASIS INHIBITION; NUCLEAR MAGNETIC RESONANCE; PATHOLOGY; PHENOTYPE;

EID: 0034124882     PISSN: 00652571     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2571(99)00026-6     Document Type: Conference Paper

References (33)

1. W. B. MACKINNON, P. A. BARRY, P. L. MALYCHA, D. J. GILLETT, P. RUSSELL, C. L. LEAN, S. T. DORAN, B. H. BARRACLOUGH, M. BILOUS and C. E. MOUNTFORD, Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy, Radiology 204, 661-666 (1997).
2. Y-L.T. TING, D. SHERR and H. DEGANI, Variations in energy and phospholipid metabolism in normal and cancer human mammary epithelial cells, Anticancer Res. 16, 1381-1388 (1996).
3. E. O. ABOAGYE and Z. M. BHUJWALLA, Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells, Cancer Res. 59, 80-84 (1999).
4. 31P NMR study in vivo and in vitro, Magn. Reson. Med. 41, 897-903 (1999).
5. P. S. STEEG, G. BEVILACQUA, L. KOPPER, U. P. THORGEIRSSON, J. E. TALMADGE, L. A. LIOTTA and M. E. SOBEL, Evidence for a novel gene associated with low tumor metastatic potential, J. Natl. Cancer Inst. 80, 200-204 (1988).
6. J. M. CONNOLLY, X-H. LIU and D. P. ROSE, Dietary linoleic acid-stimulated human breast cancer cell growth and metastasis in nude mice and their suppression by indomethacin, a cyclooxygenase inhibitor, Nutr. Cancer 25, 231-240 (1996).
7. R. REICH and G. R. MARTIN, Identification of arachidonic acid pathways required for the invasive and metastatic activity of malignant tumor cells, Prostaglandins 51, 1-17 (1996).
8. J. R. VANE and R. M. BOTTING, Mechanism of action of antiinflammatory drugs, pp. 1-23 in Eicosanoids, Aspirin, and Asthma, Lung Biology in Health and Disease. (A. SZCZEKLIK, R. J. GRYGLEWSKI and J. R. VANE, eds.) Vol. 114. Marcel Dekker, New York. (1998).
9. D. KNIGHTON, S. SCHUMERTH and V. FIEGEL, Environmental regulation of macrophage angiogenesis, pp. 150-157 in Current Communications in Molecular Biology, Angiogenesis: Mechanisms in Pathobiology. (D. B. RIFKIN and M. KLAGSBURN, eds.) Cold Spring Harbor Laboratory Cold Spring. (1987).
10. 31P MRS measurements of extracellular pH of tumors using 3-aminopropylphosphonate, Am. J. Physiol. 267, C195-C203 (1994).
11. P. VAUPEL, F. KALLINOWSKI and P. OKUNIEFF, Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review, Cancer Res. 49, 6449-6465 (1989).
12. 31P MRS as a method of measuring pH in rat tumours, NMR Biomed. 5, 351-359 (1992).
13. M. STUBBS, L. RODRIGUES, F. A. HOWE, J. WANG, K. S. JEONG, R. L. VEECH and J. R. GRIFFITHS, Metabolic consequences of a reversed pH gradient in rat tumors, Cancer Res. 54, 4011-4016 (1994).
14. H. F. DVORAK, Tumors: wounds that do not heal. Similarities between tumor and stroma generation and wound healing, N. Engl. J. Med. 315, 1650-1659 (1986).
15. 2 in inflammatory diseases, Clin. Chem. 39, 2453-2459 (1993).
16. L. J. MARNETT, S. W. ROWLINSON, D. C. GOODWIN, A. S. KALGUTKAR and C. A. LANZO, Arachidonic acid oxygenation by COX-1 and COX-2, J. Biol. Chem. 274, 22,903-22,906 (1999).
17. R. A. KARMALI, K. CHOI, G. OTTER and F. SCHMID, Eicosanoids and metastasis: experimental aspects in Lewis lung carcinoma, Cancer Biochem. Biophys. 9, 97-104 (1986).
18. A. M. FULTON, The role of eicosanoids in tumor metastasis, Prostaglandins Leukot. and Essent. Fatty Acids 34, 229-237 (1988).
19. M. NOGUCHI, D. P. ROSE, M. EARASHI and I. MIYAZAKI, The role of fatty acids and eicosanoid synthesis inhibitors in breast carcinoma, Oncology 52, 265-271 (1995).
20. D. HWANG, D. SCOLLARD, J. BYRNE and E. LEVINE, Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer, J. Natl. Cancer Inst. 90, 455-460 (1998).
21. H. WOLFF, K. SAUKKONEN, S. ANTTILA, A. KARJALAINEN, H. VAINIO and A. RISTIMAKI, Expression of cyclooxygenase-2 in human lung carcinoma, Cancer Res. 58, 4997-5001 (1998).
22. S. KARGMAN, G. O'NEILL, P. VICKERS, J. EVANS, J. MANCINI and S. JOTHY, Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer, Cancer Res. 55, 2556-2559 (1995).
23. M. TSUJII, S. KAWANO and R. N. DuBOIS, Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential, Proc. Natl Acad. Sci. USA 94, 3336-3340 (1997).
24. T. M. PAINE, H. D. SOULE, R. J. PAULEY and P. J. DAWSON, Characterization of epithelial phenotypes in mortal and immortal human breast cells, Int. J. Cancer 50, 463-473 (1992).
25. J. A. PLUMB, R. MILROY and S. B. KAYE, Effects of the pH dependence of 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay, Cancer Res. 49, 4435-4440 (1989).
26. O. H. LOWRY, N. J. ROSEBROUGH, A. L. FARR and R. J. RANDALL, Protein measurement with the folin phenol reagent, J. Biol. Chem. 193, 265-275 (1951).
27. U. K. LAEMMLI, Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature 227, 680-685 (1970).
28. H. TOWBIN, T. STAEHELIN and J. GORDON, Electrophoretic transfer of protein from polyacrylamide gels to nitrocellulose sheets: Procedures and some applications, Proc. Natl. Acad. Sci. (USA) 76, 4350-4354 (1979).
29. E. M. GILHOOLY and D. P. ROSE, The association between a mutated ras gene and cyclooxygenase-2 expression in human breast cancer cell lines, Int. J. Oncol. 15, 267-270 (1999).
30. 2, J. Biol. Chem. 274, 11,660-11,666 (1999).
31. 2 in ras-transformed and immortalized human mammary epithelial cells, Cancer Lett. 86, 11-21 (1994).
32. 2 in patients with various malignant tumors, Enzyme 43, 80-88 (1990).
33. M. TSUJII, S. KAWANO, S. TSUJI, H. SAWAOKA, M. HORI and R. N. DuBOIS, Cyclooxygenase regulates angiogenesis induced by colon cancer cells, Cell 93, 705-716 (1998).